Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up)
Clinical Trial ID: NCT03620747
Learn about this trial.
Check the eligibility requirements, study details, and more.
Clinical Trial ID: NCT03620747
Check the eligibility requirements, study details, and more.